Skip to main content

Soft Tissue Infections

1
Pipeline Programs
4
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Genentech
GenentechCA - Oceanside
1 program
1
Standard carePhase 21 trial
Active Trials
NCT00303589Completed313Est. Oct 2007
SPARK Biopharma
SPARK BiopharmaKorea - Seoul
1 program
Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).N/A1 trial
Active Trials
NCT01790698Completed409Est. Jan 2018
Roche
RocheSTAVANGER NORWAY, Norway
1 program
Standard carePHASE_23 trials
Active Trials
NCT03819335Completed28Est. Apr 2021
NCT03753490Active Not Recruiting3,933Est. May 2028
NCT01317498Completed650Est. Jun 2018
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
daptomycinPHASE_41 trial
Active Trials
NCT00102947Terminated72Est. Nov 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Merck & Co.daptomycin
GenentechStandard care
RocheStandard care
RocheStandard care
SPARK BiopharmaSystems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
RocheStandard care

Clinical Trials (6)

Total enrollment: 5,405 patients across 6 trials

NCT00102947Merck & Co.daptomycin

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Start: Jan 2005Est. completion: Nov 200672 patients
Phase 4Terminated
NCT00303589GenentechStandard care

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

Start: Dec 2005Est. completion: Oct 2007313 patients
Phase 2Completed
NCT03819335RocheStandard care

¿Can mySugr App Improve Knowledge and Self-management of People With Type 1 Diabetes Mellitus?

Start: Apr 2019Est. completion: Apr 202128 patients
N/ACompleted
NCT03753490RocheStandard care

ABC-Scores for Reduction of Stroke and Mortality in Atrial Fibrillation - The ABC-AF Study

Start: Oct 2018Est. completion: May 20283,933 patients
N/AActive Not Recruiting
NCT01790698SPARK BiopharmaSystems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

Start: Jan 2013Est. completion: Jan 2018409 patients
N/ACompleted
NCT01317498RocheStandard care

The VMVN Study: Virological Monitoring in Viet Nam

Start: Apr 2011Est. completion: Jun 2018650 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.